Monitor respiratory function in patients with underlying airway disease.
Common
Serious
Influenza virus vaccine, live- do not administer within 2 weeks before or 48 hours after zanamivir
Antimicrobial class: Antiviral, Neuraminidase inhibitor
Pregnancy category: C
Average serum half life: 2.5-5.1 hours
Precautions: Administration by mechanical ventilator or reconstitution in any liquid for nebulization is not recommended.
Use not recommended with underlying airway disease, such as asthma or COPD.
Discontinuation recommended if bronchospasm or decline in respiratory function develops.
Discontinue if allergic reaction occurs or is suspected.